10.18 -0.07 (-0.68%)
SSRX
Stock Details
Last Trade:10.18 Change:-0.07 (-0.68%) Prev Close:10.25 Open: 10.26 Days Range:10.16 – 10.35 52 Week Range: 4.18 - 14.45 Volume:165450 P/E: N/AEPS:0.00
View AllRecent Alerts 02/10/10
Recent Alert on 02/08/10 at 7:29am
3SBio (SSRX) Announces Nephoxil Marketing and Development Collaboration
3SBio (SSRX) Announces Nephoxil Marketing and Development Collaboration
3SBio Inc. (NASDAQ: SSRX) today announced a collaboration and license agreement with Panacor Bioscience Ltd. to develop and commercialize its Nephoxil pharmaceutical product for the treatment of hyperphosphatemia in China. Nephoxil (ferric... Read More
Recent Alert on 02/08/10 at 7:29am
3SBio (SSRX) Announces Nephoxil Marketing and Development Collaboration
3SBio (SSRX) Announces Nephoxil Marketing and Development Collaboration
Recent Alert on 01/08/10 at 7:05am
3SBio (SSRX) Submits Application to China SFDA for Feraheme Iron Therapy
3SBio (SSRX) Submits Application to China SFDA for Feraheme Iron Therapy
Recent Alert on 01/08/10 at 7:05am
3SBio (SSRX) Submits Application to China SFDA for Feraheme Iron Therapy
3SBio (SSRX) Submits Application to China SFDA for Feraheme Iron Therapy
View AllRecent Press Releases
Press Release on 02/08/10 at 6:04am
3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia
3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia
View AllRecent SEC Filings
No Recent SEC Filings Available